Marc Koch, MD, MBA, is an anesthesiologist and president and CEO of Somnia Anesthesia Services. Q: What are the major challenges ASCs face with regard to addressing their anesthesia needs? Dr. Marc Koch: One of major challenges is…
The Latest
The AAAHC Institute for Quality Improvement, a not-for-profit subsidiary of the Accreditation Association for Ambulatory Health Care, has announced the winners of the 2010 Bernard A. Kershner Innovations in Quality Improvement Awards.
Here are 10 current topics on orthopedic and spine-driven ASCs.
The CMS Conditions for Coverage have changed drastically in the last two years, says Sandy Berreth, administrator of Brainerd Lakes Surgery Center and a AAAHC surveyor. Changes to one such regulation, 416.41, present challenges for ASCs as it addresses an organization's…
Alan Beyer, MD, of Orthopedic Surgery Center of Orange County in Newport Beach, Calif., discusses four ways the surgery center has expanded orthopedic practice at the surgery center.
Jeannie Pezone, administrator at West Park Surgery Center in Pinellas Park, Fla., explains the process the surgery center uses to ensure medication reconciliation is achieved according to standards set by the Accreditation Association of Ambulatory Health Care.
In July I wrote an article on "Maximize Reimbursement: 4 Strategies for Success", which can be found by clicking here. Here is a follow-up article containing strategies on maximizing the accounts receivable (A/R) process.
Genascis CEO Ed Gallo is responsible for the company's roll-out of a single-source revenue cycle solution for ASCs, an initiative that Genascis says significantly reduces frustration with the revenue cycle and facilitates faster compensation for ASCs.
The number of insured Americans dropped in 2009 for the first time since the government began using comparable data in 1987, and several other measures hit new lows, according to a release by the U.S. Census Bureau.
The Drug Enforcement Administration is looking to designate propofol as a "scheduled" drug, which would tighten restrictions on the drug's distribution and use, according to an Anesthesiology News report.